Celebrate Survivorship – Give Towards Melanoma Research
Melanoma knows no boundaries. It’s a disease that affects people of all ages, races, and backgrounds. And it’s a devastating…
12/05/2023
Celebrate Survivorship – Give Towards Melanoma Research
Melanoma knows no boundaries. It’s a disease that affects people of all ages, races, and backgrounds. And it’s a devastating…
|
11/14/2023
Melanoma Cancer and Financial Toxicity
While being diagnosed with cancer alone can put a person under tremendous amounts of mental and emotional stress, the additional…
|
10/31/2023
National Family Caregiver Month
National Caregiver Month is observed every November to honor and appreciate the selfless individuals who dedicate their lives to caring…
|
10/23/2023
Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial Published: Oct 21, 2023 Data published in New…
|
|
10/15/2023
Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
October 13, 2023 17:30 ET| Source: Bristol Myers Squibb In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant…
|
|
10/13/2023
That Good Night: Life and Medicine in the Eleventh Hour
A growing discipline, palliative care medicine remains underutilized. Studies suggest that patients and providers commonly confuse palliative care with end-of-life…
|
09/17/2023
Notes from the Lab: Novel targets for immune checkpoint inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
|
09/12/2023
Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
|
09/07/2023
In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here
By Kim Margolin, M.D., FACP, FASCO Understanding the principles adjuvant therapy for adult cancers so we can apply this understanding…
|
08/28/2023
Survivor Profile: Tricia Riffenburgh, Stage IV Melanoma
By Mara Klecker At 52, Tricia Riffenburgh felt fit, healthy and grateful for her life. She was a successful consultant…
|
Recent Posts
Dec. 05, 2023
Celebrate Survivorship – Give Towards Melanoma Research
Nov. 14, 2023
Melanoma Cancer and Financial Toxicity
Oct. 31, 2023
National Family Caregiver Month
Oct. 23, 2023
Immunocore Presents Three-Year Overall Survival Data from the KIMMTRAK Phase 3 Trial
Oct. 15, 2023